Intrinsic Therapeutics, Inc. is a commercial-stage company marketing an implant designed to reconstruct herniated lumbar discs. Intrinsic’s proprietary Barricaid® anular prosthesis is a barrier that securely closes ruptures in the anulus fibrosus following a standard discectomy procedure. Anular ruptures lead to disc herniations, sciatica, and low back pain and result in over 1,000,000 surgical procedures annually. The Company has completed enrollment of their pivotal trial and is in the final stages of submitting their PMA for FDA review.